ML20115F481

From kanterella
Jump to navigation Jump to search
Applicant Exhibit A-3,consisting of Jan 1994 Curriculum Vitae
ML20115F481
Person / Time
Site: Neely Research Reactor
Issue date: 05/29/1996
From:
AFFILIATION NOT ASSIGNED
To:
References
REN-A-003, REN-A-3, NUDOCS 9607170276
Download: ML20115F481 (43)
v • d • e


Text

04/30/1995 09:33 4048539325 GATECH NNRC PAGE 02 1

e s

f 'b DOCKETED USHRC 96 JUL 10 A9 52 CURRICULUM ^

January 1994 f0C gg (( R C I, PERSONAL RECORD BRANCH

1. NAME: Rodney Dean Ice j
2. SEX: Male
3. BORN: April 24, 1937, Port Lewis, Washington
4. MARRIED: March 21, 1958, Olympia, Washington
5. WIFE'S MAIDEN NAME: Joan Elizabeth McCullough
6. CHILDREN: Randal Dean Ice, April 6, 1959 Rex Daryl Ice, February 19, 1961 Ronald Dale Ice, April 30, 1963 >
7. EDUCATION:
a. William Winlock Miller High School, Olympia, WA, 1955
b. University of Washington, Seattle, WA, B.S.

Pharmacy, 1959

c. Purdue University, West Lafayette, IN, M.S., 1965
d. Purdue University, West Lafayette, IN, Ph.D., 1967
8. GRADUATE TRAINING
a. 1965, M.S.

Major: Radiological Health Minor: Public Health (Sanitary Engineering)

Minor: Analytical Chemistry

. b. 1967, Ph.D.

Major: Radiological Health Minor: Pharmaceutics

9. ACADEMIC APPOINTMENTS and/or EXPERIENCE
a. 1992-present, Principal Research Scientist, Manager of Office of Radiation Safety, Georgia Institute of Technology, and Adjunct Professor, Health Physics Program, Georgia Institute of Technoloav.

NUCLEAR REGULATORY COMM SSION Docket No. S C e ((ac - /C 6 A} EXHlBIT NO. 3 In the rnatter of /im , di , A 9607170276 960529 ADOCK 0500 0 O staff cfApplicant O intervenor O other

{DR BTdentified @eceived O Rejected Reporter WLW Dategtdpg_LWitnessj

04/30/1996 09:33 6048539325 GATECH NNRC PAGE 03 b 1985-1992, Vice President and Director of Research, Eagle-Picher Industries (NYSE), Inc. (Self-Supporting Research Facility, $10M budget, 55 person staff).

c. 1983-1985, Vice President of Corporate Development, Benedict Nuclear Pharmaceuticals, Golden, CO.

(Responsible for Research Department, Professional Affairs Department and University Liaison Office).

d. 1976-1983, Dean and Professor of Pharmacy, College of Pharmacy, University of Oklahoma, Health Sciences Center, Oklahoma City, OK. (Responsible for $2M budget, 25 full-time faculty, 40 adjunct faculty, and 400 students)
e. 1976-1983, Assoc. Prof., Dept of Radiology, School of Medicine, University of Oklahoma, Oklahoma City, OK. I
f. May-September 1982, Visiting Scholar ; University of Michigan, Ann Arbor, MI.
g. 1976, Professor of Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI. (Taught Health Physics and Radioisotopes in Medicine).
h. 1971-1976, Assistant and Associate Professor of Internal Medicine, University of Michigan, Ann Arbor, MI.
i. 1971-1976, Associate Professor of Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI.
j. 1971-1976, Director, Radiopharmaceutical Services, University Hospital, University of Michigan, Ann Arbor, MI.
k. 1970-1971, Associate Professor of Radiochemistry, j

- Temple University, Philadelphia, PA. (Taught graduate courses in Radioisotope Methodology, Health Physics and Nuclear Pharmacy). I

1. 1967-1970, Assistant Professor Radiochemistry, Temple University, Philadelphia, PA.
m. 1967-1970, Radiation Safety Officer, Temple University, Philadelphia, PA. j
n. Health Physics Society Summer School
1) Philadelphia, PA, July 2-6, 1980  ;
2) New Orleans, LA., May 28-June 1, 1984

m neseernwa emawrwuq mm 4

o. May 19-23, 1969, Course on "Non-Ionizing Radiation,"

U.S.P.H.S., Bethesda, MD.

p. 1964-1967, Radiological Health Fellow, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN.
q. 1959-1965, Owned and Operated Rod's Tanglewilde Drugs, 6515 Martin Way, Olympia, WA.
r. 1955-1959, Pharmacist and Intern, Freed's Pharmacies, Seattle, WA: Gillette and Guffey Drugs, Olympia, WA.
10. CONSULTING POSITIONS
a. National Assn. Boards of Pharmacy 1974-1986
b. University of Tennessee, Memphis 1980
c. Department of Health, City of Philadelphia, 1968-1976
d. Veterans Administration Hospital, Ann Arbor, MI 1972-1976
e. Veterans Administration Hospital, Allen Park, MI 1976
f. Searle Laboratories, Chicago, Illinois, 1975
g. Smith, Kline and French, Philadelphia, PA 1970
h. Philadelphia Technical Institute, Philadelphia, PA 1968-1969
11. CERTIFICATION AND LICENSURE
a. Certified Health Physicist, American Board of Health Physics, 1972 (Recertified, 1980, 1985, 1990)
b. Washington State Board of Pharmacy, 1959-Present
c. California State Board of Pharmacy, 1959-Present
d. Michigan State Board of Pharmacy, 1972-1988 ,
e. Oklahoma State Board of Pharmacy, 1977-Present 3

~

04/30/1996 09:33 4048539325 GATECH NNRC PAGE 05 4

12. MILITARY SERVICE
a. 1981-Present, COL., USAR, Medical Service Corps
b. July, 1958, Commissioned Officer, Medical Service Corps
c. 1957-1958, Graduate, Washington Military Academy (Infantry, officers Candiate School)
d. 1953-1963, Washington State National Guard
13. HONORS
a. Rho Chi
b. Sigma Xi
c. Dean's List
d. International Scholars Directory
e. Who's Who in the Midwest, 15th and 16th Ed.
f. American Men and Women of Science, 13th, 14th, 15th and 16th Ed.
g. Dictionary of International Biography, Vol. 14 and 18
h. Who's Who in Health Care,1st & 2nd Ed.
i. Community Leaders and Noteworthy Americans, Am.

Biograph. Inst.

j. Who's Who in the World, Vol. 6
k. University of Oklahoma Alumni, outstanding Pharmacist Award, 1979
1. Personalities of the South, 10th & lith Ed.
m. American Biography of the Medical Sciences, 1978
n. Who's Whoein, 2 23rd Ed-r the.

W South i ci g aand gphSouthwest, (d, 17th, 20th,jf

o. Directory _ot.Muclear Medicine, Butterworth, 1981
p. Who's Who in America, 42nd, 43rd & 44th Ed.

4 i

04/30'[996 09:33 4048539325 GATECH bNRC PAGE 06

q. American Pharmaceutical Association, Academy of Pharmacy Practice, Service Award, 1983
r. Biographical Directory of Occupational and safety Specialists, 1st Ed.
s. Purdue University "Old Master" Award, 1986
t. Who's Who in Science and Engineering, 1st Ed., 1992-1993
u. Who's Who in American Education, 3rd Ed.
v. Ponca City, Oklahoma Service Recognition Award, 1991
w. Who's Who, Environmental Registry, 1992

. x. Oxford's, Whose Who, 1992

\, 7., '"? - MtiZY.i . a , . .,

14. MEMBfRSNYE$j'YN PROFESSIONAL SOCIETIES a 1991-present Internations Isotope Society
b. 1955-present American Pharmaceutical Association
c. 1967-present American Association for the Advancement of Science
d. 1965-present Health Physics Society
e. 1970-present American Scientific Affiliation
f. 1971-present Society of Nuclear Medicine
g. 1968-present American Association of Colleges of l "- Pharmacy
h. 1976-1983

'~ Oklahoma State Pharmaceutical Association

1. 1973-ifD ~ American Institute History of Pharmacy
j. 1955-1976 Washington State Pharmaceutical Assn.
k. 1955-1974 American Public Health Assn.
1. 1968-1974 Conferencc of Radiological Health
m. 1967-1971 Delaware Valley Radiation Protection Society
n. 1959-1965 Southwest Washington Pharmaceutical Assn.
o. 1962-1963 Puget Sound Pharmaceutical Assn.
15. POSITION HELD IN ABOVE SOCIETIES
a. American Association of Col.leges of Pharmacy
1) Delegate, 1975, 1976, ~1977, 1978
2) Academic Affaira Commf.ttee, 1976, 1977, 1978
b. American Pharmaceutical Association
1) Chairman, Nuclear Pharmacy Section, Academy of Pharmacy Practice, 1977-1978
2) Nuclear Pharmacy Committee of Legislative

+ Affairs, 1976

3) Nominating Committee, 1979-1980
4) Regulatory Affairs Committee 1980-1981, 1983-1C84 5

04/30/1996 09:33 4048539325 GATECH NNRC PAGE 07 l .-

l l

c. Delaware Valley Radiation Protection Society, President Elect, 1969; President, 1970
d. Delegate to American Pharmaceutical Association Meeting, Washington State, 1964 Academy of Pharmacy Practice, 1978
i. Oklahoma State, 1981
e. Southwest Washington Pharmaceutical Association Secretary, 1960-1961 President Elect, 1962 President, 1963
16. COMMITTEE AND ADMINISTRATIVE SERVICE ign .ms t uw**
  • re e . .. > > .- "* . ...,< , L . .,. 1. . ; c . ; . . v .s . ' - ' **t
1. 1980-1990, Revision Committee, United States i Pharmacopeia l 1977-1984, Board of Pharmaceutical Specialties, 2.

Specialty Council of Nuclear Pharmacy.

3, 1968-1985, Representative of the American' Pharmaceutical Association to the United States Standards Institute Committee, N-44, " Equipment l and Materials for Medical Radiation Applications."

l

4. 1976-1978, Trustee, Radiopharmaceutical Science Council, Society of Nuclear Medicine
5. 1976-1979, Editorial Advisory Board, U.S.

Pharmacist New York, NY l

6. 1974-1977, American Association of Colleges of Pharmacy, Subcommittee of Nuclear Pharmacy, (Chairman, 1976)
b. State
1. 1980-81, Membership Committee, oklahoma Pharmaceutical Assn., State of Oklahoma
2. 1975-1976, Chairman, Radiopharmaceutical Advisory Advisory Committee, Michigan Board of Pharmacy, Department of Licensing and Regulation, State of Michigan

, 3. 1973-1976, Chairman, Governor's Radiation j Advisory Committee, state of Michigan.

i 4

4 6

g g gg gggg ygeg3 egegg353gg GATECH NNRC PAGE OS

c. University of Oklahoma 1.

2.

1981-1982, HSC LRP, and Affirmative Action 3.

1979-1982,sOK Teaching Hospitals P & T Committee 1976-1983 dRadiation Safety Committee

4. 1976-1983, Dean's Council 5.

1976-1983, V.A. Administration Dean's Committee

d. University of Michigan 1.

2.

1975-1976, Chairman, Graduate Affairs Committee 1973-1976, Educational Resources Committee 3.

1972-1976, Executive Committee, College of Pharmacy

4. 1972-1973, Faculty Senate
5. 1974-1975, Alumni Lecture Committee
6. 1972-1976, Graduate Research Support Committee
e. Temple University  !
1. 1970-1971, Head, Bionucleonics Division (Radiological Health, Nuclear Pharmacy, Radiation 2.

Safety Office, 4 Faculty, 7 Staff)

April 18-19, 1969, Chairman Workshop on Thermoluminescent dosimetry, Jefferson Medical Center, Jefferson University, Philadelphia, PA

3. 1967-1971, Radiation Protection Committee a.

b.

University Policy Committee (Chairman 70-71)

4. Health Human 1969-1971, Sciences Use(Chairman Committe 1967-1971)
5. 1968-1971, School of Pharmacy
a. 1968-1970, Equipment Committee (Chairman 69-70)
b. 1968-1969, Admissions Committee
c. 1968-1969, Graduate Committee
d. 1968-1971, Student Activites Committee
6. 1968-1971, Faculty Advisor, Phi Delta Chi Pharmacy Faternity 7

1967-1970, Administered Radiation Safety Office (6 staff)

f. Reviewer (Current)
1. The Journal of Nuclear Medicine
2. Am. J. Hospital Pharmacy
3. Journal of Medicinal Chemistry
4. Encyclopedia of Chemical Technology t

7

--- __ _ _ _ . - - . . _ _ . _ . . _ _ _ . _ . _ . _ _ _ . _ _ _ ~ _ _ _. . _ . _ . _ _ _.

04/33/1996 09:33 4048539325 GATECH NNRC PAGE 09 4 ,

J 4

4

17. COMMUNITY SERVICE
a. 1991-present, Board of Trustees, Bacone College, Muskogee, OK.
b. 1991 Technical Advisory Committee, City of Miami,0K
c. 1989 - present, Member, Management Advisory Board, i

1 Center for Space Power, Texas A&M University

d. 1975, Executive Chairman for Billy Graham Assn.,

j Washtenaw Co., "The Hiding Place" film.

e. 1974, Executive Chairman for Billy Graham Assn.,

Washtenaw Co., " Time to Run" film.

f. 1971-1980, Board of Trustees, Philadelphia College of Bible, Philadelphia, PA.
g. Church Membership
1. 1987-present, First Baptist Church, Miami, OK 4 (Adult Sunday School Teacher, Choir)
2. 1977-1981, Metropolitan Baptist Church, Oklahoma
City, OK
3. 1971-1977, Packard Road Baptist Church (Adult Sunday School Teacher, Deacon, choir)
4. 1968-1971, Wharton Baptist Church, Philadelphia, PA (Sr. High Sunday School Teacher, Choir, Deacon)
5. 1964-1968, First Baptist Church, Lafayette, IN (Substitute Sunday School Teacher) ...

~

6. 1953-1964, First Baptist Church, Olympia, WA (Sunday School Teacher, Sunday School Superintendent, choir, Junior Hich Youth Leader) )
, h. 1970-present, Gideons International (President, Ann a

Arbor Camp-1973)

i. 1961-1964, Christian Business Men's Club, Olympia, WA j II. BIBLIOGRAPHY l

3 A. Publications

1. Ice, R.D., Master's Thesis: A Study of the Retention, Excretion, and Distribution of 2,3,5-Triiodobezoic Acid i and Its Metabolites in the Rat, Graduate School, Purdue l University, Lafayette, IN., August, 1965.

4

2. Ice, R.D., Breckinridge, C.E., Jr., and Christian J.E.: Retention, Excretion and Distribution of 2,3,5-

. Triiodobezoic Acid and Its metabolites in the Rat, J.

i Pharm. Sci., 55: 497-500, 1966.

3

3. Ice, R.D., Doctoral Dissertation: The Metabolic Fate
of Orally Administered 2,3,5-Triiodobenzoic Acid and

. Its Metabolites in Lactating Animals, Graduate School, j Purdue University, Lafayette, IN., June, 1967.

1 l

l i

i g 1

~~ ~ ~

04/30/1996 ~09: 33 " ~4048539325~ 5TECHiERC"' PhGE 10

4. Ice, k.D. , Christian, J.E. , arid Plumlee, M.P. :

Metanolic Fate of orally Administered 2,3,5-Triiodobenzoic Acid in Lactating Animals, J. Pharm.

Sci., 57: 399-404, 1968. '

5. Dugan, M.A., and Ice, R.D.: Beta Emitter Indentification by Quench Analysis, organic Scintillators and Liquid Scintillation Counting, Horrocks, D.L. and Peng, C.T., Ed., 1055-1062, Academic Press, 1971.
6. Ice, R.D.: Establishment of a University Radiation Safety Office, Health Physics, 20: 444-446, 1971.
7. Ice, R.D. and Dugan, M.A.: Beta Radiopharmaceutical Identification by Quench Analysis, J. Nucl. Med., 12: l 552-554, 1971.
8. Ice, R.D., Updegrave, W.J. and Bogucki, E.I.:

Influence of Dental Radiographic Cones on Radiation Exposure, J.A.D.A., 83: 1297-1302, 1971.

9. Bercz, C.V. and Ice, R.D.: Synthesis of 1-Carbethoxy cyano-4-phenylpiperidine, J. Pharm. Sci., 61:
  • 1316-1317, 1972.
10. Lieberman, J.E., Ice, R.D., Green, M. and McGratten, R: Summary of Environmental Monitoring at i Philadelphia, 1958-1971, Radiological Health Data and Reports, 14: 333-350, 1973. ,
11. Kirschner, A.S., Ice, R.D., and Beierwaltes, W.H.:

Radiation Dosimetry of I-19-Iodocholesterol, J. Nucl.

Med. 14: 713-717, 1973.

12. Kelly, W.N. and Ice, R.D.: Pharmaceutical Quality of Technetium-99m Sulfur Colloid, Am. J. Hosp. Pharm.,

30: 817-820, 1973.

13. Ice, R.D. and Hetzel, K.R.: Radiation Protection in a Nuclear Pharmacy, Proceedings of the Third International Congress of t!.e International Radiation Protection Association, Sept. 9-14, 1973, Washington, D.C., 1197-1202. Conf. 730907, USAEC, Oak Ridge, TN.
14. Hotte, C. and Ice, R.D.: Thermal and Radiolytic Decomposition of 131-I-19-Iodocholesterol, J. Nucl.

Med., 15: 38-41, Jan.,1974.

i i

9 i l

~

~ ~~

~ 04/33/1996' lei 36 ~ ~4048539325 GATECH NNRC PAGE 02 l I I

i l l

15. Clayton, B.D., Ice, R.D. and Beierwaltes, W.H.:

Preparation, Quality control and Clinical Acceptance of 223-225, July, labelled Macrotec, Radiology, 116:

1975.

16. Anderson, B.G., Beierwaltes, W.H., Harrison, T.S.,

Ansari, A.N., Buswink, A.A. and Ice, R.D.: Labelled Dopamine Concentration in Pheochromacytomas, J. Nucl.

Med., 14: 781-784, Nov., 1973.

17. Ice, R.D., Shaw, S.M., Born, G.S. and George,R.E.:

Nuclear Pharmacy Education., American Journal of Pharmacy Education, 38: 420-425, Aug., 1974. l l

Sturman, M.F., Beierwaltes, W.H., Prakash, S., Ryo, I

l 18.

U.Y., Ice, R.D. and Gitomer, W.: Uptake of Radiolabeled Testosterone, 5-Dihydrotestosterone, Estradiol and Pregnenolone by Canine Prostate., J. l Nucl. Med., 15: 94-97, February, 1974.

19. Beierwaltes, W.H., Sturman, M.F., Ryo, U.Y. and Ice, R.D.: Imaging Functional Nodules of the Adrenal Glands with I-19-Iodocholesterol., J. Nucl. med., 15: 246-251, April, 1974. ,

and Ice, R.D.:  ;

20. Fyo, U.Y., Beierwaltes, W.H.  ;

Enhancement of Uptake with Estradiol Treatment of A Radiolabeled Irreversible Competitive Enzyme Inhibitor l in the Adrenal Cortices and Ovaries of RatsNucl. with Hed.,

Endocrine Autonomous Breast Carcinoma., J.

15: 187-189, March, 1974.

and Ice,

21. Ryo, U.Y., Beierwaltes, W.H., Freehan, P.

R.D.: Distribution of 14-C and 3-H-Streptozotocin in Dogs and Toadfish, J. Nucl. Med., 15: 572-576, July, 1974.

22. Sturman, M.F., Moses, D.C., Beierwaltes, W.H.,

Harrison, T.S., Ice, R.D. and Dorr, R.P.:

Radiocholesterol Adrenal Images for the Localization of Pheochromacytoma, Surg., Gyn., and Obst., 138: 177-180, February, 1974.

23, MacAuley, R.J., Ice, R.D. and Curtis, E.G.: The Linulus Test for ID vitro Pyrogen Detection, Am. J.

Hosp. Pharm., 31: 688-691, July, 1974.

l 10

m *"*ww eMEMWL MC~M3

(

24. Ryo, U.Y., Shaw, M.J., Beierwaltes, W.H., and Ice, R.D.: Distribution of 14-C-Diphenylhydantoin in Pancrease Islet Cell and Other Tissue of Toadfish., J.

Nucl. Med., 15: 685-687, August 1974.

25. Ice, R.D. and Hetzel, K.R.: Nuclear Pharmacy Health l

l Physics., " Selected Papers on Nuclear Pharmacy,"

i American Pharmaceutical Association, Washington, DC.

l January, 1976, pp. 39-44.

26. Hetzel, K.R. and Ice, R.D.; Clinical Nuclear Pharmacy, ,

" Selected Papers of Nuclear Pharmacy", American Pharmaceutical Association, Washington, DC, January, l

l 1976, pp. 31-38.

t l 27. Shen, V., Hetzel, K.R. and Ice, R.D.: Radiochemical

! Purity of Radiopharmaceuticals Using Gelman Seprachrome I (ITLC) Chromatography, Gelman Technical Bulletin, No. 1 i 32, Gelman Instrument Co., Ann Arbor, Michigan, 1 October, 1974. l

28. Moses, D.C., Schteingart, D.E., Sturman, M.F.,

Beierwaltes, W.H. and Ice, R.D.: Efficacy of Radiocholesterol Imaging on the Adrenal Glands in Cushing's Syndrome., Surg., Gyn., and obst., 139: 201-205, August, 1974.

l

29. Sturman, M.F., Beierwaltes, W.H., Ice, R.D. and l Prakash, S.: Uptake of Radiolabeled Estradiol by the Canine Adrenal, J. Nucl. Med., 16: 77-79, January, 1975.
30. Ryo, U.Y., Ice, R.D., Jones, J.D. and Beierwaltes, W.H.: Relative Tissue Distribution of Radioactivity in Rats with Endocrine " Autonomous" Breast Carinomas After 3-H , 99m-Tc , and 64-Cu-Bleomycin, J. Nucl. Med., 16:

127-131, February, 1975.

31. Lamson, M.L., Kirschner, A.S., Hotte, C.E., Lipsitz, l E.L. and Ice, R.D.: Generator Produced 99m-Tc04:

l Carrier Free?, J. Nucl. Med., 16: 639-641, July, 1975.

32. Blau, M., Kirschner, A.S., Ice, R.D. and Beierwaltes, W.H.: Radiation Dosimetry of 131-I
  • Iodocholesterol: The Pitfalls of Using Tissue Concentration Data., J. Nucl. Hed., 16: 247-250, March, 1975.

11

04/30/1996 10:39 4048539325 GATECH NNRC PAGE 04

33. Anderson, B.G., Beierwaltes, W.H., Nishiyama, R.H., and Ice, R.D. Effect of Large Doses of 131-I Iodocholesterol on Metapyralone Induced Adrenal Cortical Hyperlasia in Dogs., J. Nucl. Med. 16: 928-932, October, 1975.
34. Blachandran, S., Beierwaltes, W.H., Ice, R.D., Fajans, S.S., Ryo, U.Y., Redmond, M.J., Hetzel, K.R., Mosley, S.T. and Feldstein, B.: Tissue Distribution of 14-C-125-I , and 131-I-Diphenylahydantoin in the Toadfish, Rat and Humans with Insulinomas, , J. Nucl. Med., 16:

775-779, August, 1975.

35. Basmadjian, G.P., Hetzel, K.R. and Ice, R.D.: New Methods for Introducing 75-Se into Radiopharmaceuticals, Int. J. App. Rad. and Isotopes, 26: 695-697, Nov. 1975.
36. Ice, R.D., Wieland, D.M., Beierwaltes, W.H. and Lawton, R.G.: Concentration of Dopamine Analogs in the Adrenal Medulla, J. Nucl. Med., 16: 1147-1151, December, 1975. l l
37. Porter, W.C., Ice, R.D. and Hetzel, K.R.:

Establishment of Nuclear Pharmacy., Am. J. Hos>.

Phars., 32: 1023-1027, October, 1975.

38. Sarkar, S.D., Beierwaltes, W.H., Ice, R.D., Basmadjian, G.P., Hetzel, K.R., Kennedy, W.P. and Mason, M.M.: A New and Superior Adrenal Scanning Agent: NP-59., J.

Nucl. Med., 16: 1038-1042, November, 1975.

39. Hetzel, K.R. and Ice, R.D.: Pitfalls in Radiometric Sterility Assay., J. Nucl. Med., 16: 798, August, 1975.
40. Basmadjian, G.P., Hetzel, K.R., Ice, R.D. and Beierwaltes, W.H.: Synthesis of a New Adrenal Cortex Scanning Agent, 6B-I-131-Iodomethyl-19-norcholest-5(10)-

en-3B-nl (NP-59)., J. Labelled Compounds, 11: 427-434, No. 3, 1975.

41. Sarkor, S.D., Ice, R.D., Beierwaltes, W.H., Gill, S.P.,

Balachandran, S. and Basmadjian, G.P.: 75-Se

  • Selenocholesterol--A New Adrenal Scanning Agent with High Concentration in the Adrenal Medulls, J. Nucl.

Med., 17: 212-217, March, 1976.

12

4

42. Seabold, J.E., Cohen, E.L., Beierwaltes, W.H.,

Hinerman, D.L., Nishiyama, R., Bookstein, J.J., Ice, R.D. and Balachandran, S.: Adrenal Imaging with 131-I-19-Iodocholesterol in the Diagnostic Evaluation of 4 ~ionts with Aldosteronism., J. Clinical Endocrinol.

anc Metabolism., 42: 41-51, January, 1976.

43. Beierwaltes, W.H., Ice, R.D., Shaw, M.J. and Ryo, U.Y.: Myocardial Uptake of Labelled Oleic and Linoleic Acids., J. Nucl med., 16: 842-845, September, 1975.
44. Lamson, M., Hotte, C. and Ice, R.D.: Practical Generator Kinetics, J. Nucl. Med. Techn., 4: 21-27, March, 1976.
45. Ice, R.D., Kircos, L.T., Coffey, J.L. Watson, E.E.,

Beierwaltes, W.H., and Sarkar, S.D.: Radiation Dosimetry of 6-131-I-Iodomethyl-19-norcholesterol, NP-59, Radiopharmaceutical Dosimetry Symposium Proceedings, NEW Publication (FDA) 76-8044, 246-255, June, 1976.

46. Kirschner, A.S. and Ice, R.D.: The Theoretical Effect of Radiopharmaceutical Specific Activity on Tissue Localization and Absorbed Radiation Dose.

Radiopharmaceutical Dosimetry Symposium Proceedings, HEW Publication (FDA) 76-8044, 140-151, June, 1976.

47. Ice, R.D. and Hetzel, K.R.: Hospital Radiopharmaceutical Quality Assurance, Applied Radiology /NM, 213-217, Nov.-Dec., 1976.
48. Behm, H.L. and Ice, R.D.: An Introduction to Nuclear Pharmacy,-U.S. Pharmacist, 1: 29-33, October, 1976. 1
49. Sarkar, S.D., Cohen, E.L., Beierwaltes, W.H., Ice, R.D., Cooper, R. and Gold, E.N.: A New and Superior Adrenal Imaging Agent, NP-59: Evaluation in Humans, J.

Clinical Endocrinol. and Metabolism, 45: 353-362, August, 1977.

50. Beierwaltes, N.H., Wieland, D.M., Ice, R.D., Seabold, J.E., Sarkar, S.D., Gill, S.P. and Mosley, S.T.:

Localization of Radiolabeled Enzyme Inhibitors in the Adrenal Gland, J. Nucl. Med., 17: 998-1002, Nov. 1976.

13

51. Hotte, C.E. and Ice, R.D.: Use of a Revised MIRD Equation for Dosimetric calculations in Physical Systems, Health Physics, 32: 442-443, May, 1977.
52. Hotte, C.E., Ice, R.D. and Flynn, G.L.: Radiolysis of 131-I-o-Iodophippurate: A Kinetic Study, J. Labelled Compounds and Radiopharmaceuticals, 17: 715-725, 1980.
53. Behm, H.L. and Ice, R.D.: Radiological Physics of Nuclear Pharmacy, U.S. Pharmacist 2: 50-57, January, 1977.
54. Behm, H.L. and Ice, R.D.: Nuclear Pharmacy Radiological Health, U.S. Pharma:ist 2: 42-47, March, 1977.
55. Behm, H.L. and Ice, R.D.: Organ Imaging Radiopharmaceuticals, U.S. Pharmacist 2: 64-72, May, 1977.
56. Behm, H.L. and Ice, R.D.: ID Vitro Radiopharmaceuticals, U.S. Pharmacist 2: 64-74, August, 1977.

1

57. Behm, H.L. and Ice, R.D.: Radiopharmaceutical Iunction Studies, U.S. Pharmacist 2: 70-80, October, 1977.
58. Vivian, A., Ice, R.D., Shen, V. and Hetzel, K.R.:

Procedure Manual, Radiochemical Purity of Radiopharmaceuticals Using Gelman Soprachrom Chromatography, Tech. Bulletin 32, Gelman Instrument Company, June, 1977.

59. Basmadjian, G.P. , Ice, R.D. , Magarian, R. A. , Parker, G.R., Mills, S.L. and Kirscher, A.S.: Design and Development of Te-123m Radiopharmaceuticals, Society of Nuclear Medicine, Radiopharmaceuticals II, 93-99, November 1979.
60. Gilliland, D.L., Basmadjian, G.P., Kirschner, A.S.,

Leonard, O.C. and Ice, R.D.: Development of Lymphscintigraphy Agent: Tc-Sn-PO4: Society of Nuclear Medicine, Radiopharmaceuticals II, 321-330, November, 1979.

61. Hotte, C.E. and Ice, R.D.: The In vitro Stability of 131-I-o-Iodohippurate, J. Nucl. Med. 20: 441-447, May, 1979.

14

~

04/30/1996~ 10: 47' 404E539325 GATECH NNRC PAGE 02 4

62. Basmajian, G.P., Parker, G.R., Magarian, R.A., Ice, R.D., Mills, S.L. and Kirschner, A.S.: Synthesis of Te-123m Nucleophiles: Potential Use in the Synthesis of new Te-123m Radiopharmaceuticals, Interational Journal of Applied Radiation and Isotopes, 31: 517-520, 1980.
63. Mills, S.L., Basmadjian, G.P., Parker, G.R. and Ice, R.D.: Synthesis of Te-123m Labelled Patty Acids, J. of Labelled Compounds and Radiopharmaceuticals., 18: 721-730, May 1981.
64. Hinkle, G.H., Basmajian, G.P., Kirschner, A.S. and Ice, R.D.: Evaluation of a Kit Preparation of Radiciodinated o-Iodohippuran, J. Pharm. Sci. 70: 312-316, March, 1981.
65. Hinkle, G.H., Basmadjian, G.P., Kirschner, A.S. and Ice, R.D.: A Radiopharmaceutical Kit Preparation of 123-I-Iodohippuran. Nuclear Medicine Communications 1: j 302-306, 1981. 1
66. Mills, S.L., Basmadjian, G.P., and Ice, R.D.:

Radiopharmaceuticals Used in Myocardial Imaging, J.

Pharm. Sci., 70: 1-12. January, 1981. .

67 Gilliland, D.L., Basmadjian, G.P., Marchand, A.P.,

Hinkle, G.H., Earlywine, A., and Ice, R.D.: lodine Labelled Radiopharmaceuticals from Ary1 thallium Bis-(Trifluoroacetate) Intermediates, J. Radicanalytical Chem., 65: 107-113, No. 1-2, 1981.

68. Ahluwalia, B., Allen, E.W., Basmadjian, G. and Ice, R.D.: The Role of Nuclear Pharmacy in Reducing Radiation Exposure. Health Physics, 40: 728-729, q Hay, 1981.  !
69. Donuhue, D.M., Leonard, J.C., Basmadjian, G.P.,

Nitschke, R.M., Hinkle, G.H., Ice, R.D., Wilson, D.A.

and Tunnell, W.P.: Thymic Gallium-67 Localization in Pediatric Patients on Chemotherapy. J. Nucl. Med.,

22: 1043-1048, 1981.

70. Ice, R.D. and Basmadjian, G.: Nuclear Pharmacy Ph.D.

. Programs. American Pharmacy, NS21: 569-597, Oct.

1981.

15

~

0575071995~10:A ~iN5539325 ~ GAiECkNNRC PAGE 03

71. Waschek, J., Hinkle, G , Basmadjian, G., Allen, E.W.

and Ice, R.D.: Effect of Cardiac Drugs on Imaging Studies with Thallous Chloride T1-201, Am. J. Mosp.

Pharm. 38: 1726-8, NoveEber 1981.

72. Basmadjian, G.P., Mills, S.L., and Ice, R.D.:

Synthesis Biological Distribution and Radiation Dosimetry of Te-123m Analogues of Hexadeconoic Acid, Nucl. Med. Comm., 3: 150-154, June 1982 and Proc.

of the 3rd World Congress of Nuclear Medicine and Biology, Pergamon Press, 2: 2265-2268, Sept. 1982.

73. Sadek, S.A., Basmadjian, C.P., and Ice, R.D.: Labelling radiopharmaceutical with Se-75: l Using Se-75 Selenios Acid, Nucl. Med. comm., 3: l t

247-250, Aug.1982.

i

74. Hinkle, G.H., Basmadjian, G.P., Peek, C., Barker, K.K., and Ice, R.D.:- Effects of Current Drug Therapy on Technetium Tc-99m Gluceptate Biodistribution, Am.  !

J. Hosp. Pharm. 39d: 1930-1933, Nov. 1982. l

75. Basmadjian, G., Johnston, J., Barker, K., and Ice, R.D.: Trends in Radiopharmaceutical Dispensing in a 1 Regional Nuclear Pharmacy, Am. J. Hosp. Pharm., 39:

1933-1936, Nov. 1982 and in Proc. of the 3rd World Congress of Nuclear Medicine and Biology, Pergamon Press, 4: 3240-3252, Sept. 1982.

76. James, M.R.,.Basmadjian, G.P., Leonard, J.C., and Ice, R.D.: Desferoxamine Mesylate: Its Use in Reducing Radiation Burden in Pediatric Patients Injected with Gallium-67 Citrate, Proc. of the 3rd World Congress of Nuclear Medicine and Biology, Pergamon Press, 1: 991-993, Sept. 1982.  ;
77. Grussing, P.G. , Allen, D.R. , Callahan, R.J. , Cooper, J.F., Ice, R.D., Kalman, S.H., Penna, R.P, Shaw, S.M.

and Solomon, A.D.: Development of Pharmacy's First  !

Specialty Certification Examination: Nuclear Pharmacy, l Am. J. Pharm. Ed. 47: 11-18, Spring 1983.

78. Fung, T.J., Basmadjian, G.P., and Ice, R.D.: Nuclear Pharmacy Management Information Retrieval System. Am.

J. Hosp. Pharm. 40: 818-821, May 1983.  ;

1 l

16

04/30/1995 10: 47 404C539325 GATECH NNRC PAGE 04

79. Sadek, S.A., Basmadjian, G.P., Rieger, J.A., Hsu, P.M.

and Ice, R.D.: New So-75 Labelled radiopharmaceuticals

2. Selenium Derivatives of Aralkylamines , Int. J. Appl.

Rad. Isot., 35: 35-39, Jan. 1984.

80. Chan, S.M. , Basmadjian, G.P. , Marten, D.P. , Sadek, S.D. ,

Magarian, R.A., Grunder, J.R. and Ice, R.D.: Synthesis J.

and Biodistribution of Radioiodinated-5-iodonicotine:

Labelled Compd. Radiopharm. 20: 1017-1019, 1983.

81. McAuley, R., Lull, R., and Ice, R.D.: Bromine-82 Contamination in Fission Product 99mTc-Generator Eluate, Eur. J. Nucl. Med. 10: 60-62, Jan. 1985.
82. Ice, R.D. , Boron-10 Precursor Products for Boron Neutron Capture Therapy in " Proceedings Boron Compounds Suitable for Neutron Capture Thorpy for the Treatment of Cancer",

Radiation Research Program, National Cancer Institute, May 1988.

C3. Ice, R.D. , and Porter, S.W. , Hospital Radiation Emergency Planning, in " Hospital Health Physics", Research Enterprises, Richland Washington, Publishers, 245-273, 1993. l l

l 17

- -m - vv#s,ga B. Abstracts and Articles

1. Ice, R.D. and Hall, N.: Chromatographic Analysis of the Alkaloids of Ceanothus Americanus, College of Pharmacy, University of Washington, June, 1959.
2. Ice, R.D., Breckinridge, C.E. and Christian, J.E.: A Study of the Retention, Excretion and Distribution of 2,3,5-Triiodobenzoic Acid and its Metabolites in the Rat, J. Am. Pharm. Assn., NS6, 122, 1966.
3. Ice, R.D.: Interdisciplinary Antiauxin Study, Environmental Health Communique, Purdue University, 14fayette, Indiana, 1: Nov. 2, 1966.
4. Ice, R.D.: Radiation Safety Manual, Temple University, Philadelphia, PA. July, 1967. (Revised July, 1968 and July, 1969).
5. Ice, R.D., Christian, J.E. and Plumlee, M.P.:

Metabolic Fate of 2,3,5-Triiodobenzoic Acid., American Association for the Advancement of Science, New York, December, 1967.

6. Ice, R.D.: Human Usage Radiation Safety Handbook.,

Temple University, Philadelphia, PA. July, 1968.

7. Ice, R.D.: Bionucleonics and Christianity.,

Philadelphia College of Bible, Philadelphia, PA., May, 1970.

8. Ice, R.D.: Environmental Radioassay Handbook, City of Philadelphia, June, 1970.

l

9. Dugan, M.A. and Ice, R.D.: Quench Analysis in Liquid Scintillation Counting., Proceedings of the 2nd Int. <

Conf. on organic scintillators and Liquid Scintillation Counting, University of California, San Francisco, July 1, 1970.

10. Ice, R.D.: Influence of Dental Radiographic Cones on Radiation Exposure., Health Physics, 21: 887, p. 71, 1971.

18

6 uss3W373 dAYLCWNRIE PAGE 06 4

11. Ice, R.D.: Radiation Safety in X-Ray Diffraction and Spectroscopy., DHEW Publication No. (FDA) 72: 8009 BRH/DEP 72-73, September, 1971.
12. Ice, R.D.: Radiopharmaceuticals for the Practitioner.,

University of Michigan, Ann Arbor, MI, October 1971.

13. Ice, R.D., Updograve, N.J. and Bogucki, E.I.:

Influence of Dental Radiographic Cones on Radiation Exposure., Information sur Kernforschung and Kerntechnik, IKK, p. 17, No. 11, 1971.

14. Dugan, M. and Ice, R.D.: Dosimetry of Orally Adninistered Tritiated Thymidine, Tritium Symposium, University of Nevada, September 2, 1971.
15. Briden, D. and Ice, R.D.: Neutron Measurements in a Medical Betatron X-Ray Beam., Health Physics, 23: 405-406, 1972.
16. Sturman, M.F., Beierwaltes, W.H., Ryo, U.Y., and Ice, R.D.: Imaging Functional Nodules of the Adrenal Glands in Relatively Asymptomatic Individuals., J.Nucl. Med.,

14: 458-459, 1973. .-

17. Kirschner, A.S., Ice, R.D. and Beierwaltes, W.H.:

Radiation Dosimetry of 131-I-19-Iodocholesterol., J.

j Nucl. Med., 14: 416. 1973.

1 j 18. Ice, R.D. and Hetzel, K.R.: Radiation Protection in a j Nuclear Pharmacy., Third International Congress on i Radiation Protection., International Radiation l

Protection Association., Washington, DC., September 13, 1973.

19. Ice, R.D.: How Can New Radiopharmaceuticals Be Made Available to the Greatest Number of Hospitals:

Controversy in Nuclear Medicine?, The Central Chapter Society of Nuclear Medicine Meeting, October 25-27, 1973, Indianapolis, IN.

20. Clayton, B.D. and Ice, R.D.: Preparation, Quality Control and Clinical Acceptance of Macrotec., Am. Soc.

. Hosp. Pharm. Meeting, December 10-14, 1973, New Orleans, Louisiana.

19

04/20/1995 10: 47 4048539325 GATECH NNRC PAGE 07

21. Hetzel, K.R. and Ice, R.D.: Clinical Nuclear Pharmacy., Am. Soc. Hosp. Pharm. Meeting, December 10-14, 1973, New Orleans, LA.
22. McAuley, R.J., Ice, R.D. and Curtis, E.G.:

Establishment of the Limulus Test for In vitro Pyrogen Detection, Am. Soc. Hosp. Pharm. Meeting, Dec. 10-14, 1973, New Orleans, LA.

23. Blachandran, S., Ryo, U.Y., Beierwaltes, W.H., Shaw, M.J. and Ice, R.D.: Uptake of Radiolabeled Dilantin (DHP) in Islet Cells., J. hucl. Med., 15: 476, 1974.
24. Ice, R.D., Wieland, D.M., Beierwaltes, W.H. and Lawton, R.G.: Synthesis and Concentration of Dopamine Analogs in the Rat., J. Nucl. Med., 15: 503, 1971.
25. Ice, R.D. and Hetzel, R.: Operational Aspects of a Regional Nuclear Pharmacy., American College of Nuclear Medicine Physicians, June 9, 1974.
26. Ice, R.D. and Hetzel, K.R.: Hospital Radiopharmaceutical Quality Control., Presented at the 21st Annual Meeting on the Society of Nuclear Medicine, San Diego, California, June, 1974.
27. Kirschner, A.S. and Ice, R.D.: The Theoretical Effect of Specific Activity of Specific Tissue Localization and Radiation Dosimetry of Labelled Estradiol, J. Am.

Pharm. Assn., NSl4: 297, 1974.

28. Hetzel, K.R. and Ice, R.D.: The Clinical Practice of Nuclear Pharmacy, J. Am. Pharm. Assn., NS14: 297, 1974.
29. Ice, R.D. and Hetzel, K.R.: Nuclear Pharmacy Health PhyEics., J.Am. Pharm. Assn., NS14: 297, 1974.
30. Ice, R.D.: The Practice of Nuclear Pharmacy., Alumni Bulletin, Ferris State College, Big Rapids, MI, No. 2, June, 1974.
31. Ice, R.D.: Radiopharmaceuticals and Labelled Compounds., Book Reviewed for the Amer. J. Hosp.

Pharm., 1974.

i 20

t&frfar7BMf RJI7Jr etJRfs35325 GATECH NNRC PAGE 00 '

32. Ice, R.D., Kirschner, A.S. and Ihlenfield, R.W.: The Effect of Specific Activity and Tissue Localization Units on Radiopharmaceutical Design., Acad. of Pharm.

Sci., November 11, 1974, New Orleans, Louisiana.

33. Ice, R.D.: Panel Discussion-Education in Nuclear Pharmacy., J. Am. Pharm. Assn., NS14: 297, 1974.
34. Ice, R.D.: Nuclear Medicine: Federal and Local Regulations., Third Radiopharmaceutical Workshop, William Beaumont Hospital, Royal Oak, Michigan, November 9, 1974.
35. Porter, W., Ice, R.D. and Hetzel, K.R.: Establishment of a Nuclear Pharmacy., J. Am. Pharm. Assn., NS14:

308, 1974. <

I

36. Ice, R.D.: Panel Discussion-Federal Regulations in the Practice of Nuclear Medicine., 21st Annual Meeting of the Society of Nuclear Medicine, San Diego, Californik, June, 1974. I i
37. Ice, R.D., Kirschner, A.S. and Ihlenfield, R.W.: The Effect of Specific Activity and Tissue Localization Units on Radiopharmaceutical Design., Abstracts, 17th Nat. Meeting, A.Ph.A. Academy of Pharm. Sci., 4: 36, 1974.
38. Lamson, M., Kirschner, A., Hotte, C., Lipsitz, E. and Ice, R.D.: Generator Produced 99m-TcO-4: Carrier Free?, J. Nucl. Med., 15: 541-542. June, 1975.
39. Kirschner, A.S. and Ice, R.D.: The Effect of Specific Activity on Tissue Localization and Radiation Dosimetry., J. Nucl. Med., 16: 541-542., June, 1975,
40. Basmadjian, G.P., Hetzel, K.R., Ice, R.D. and Beierwaltes, W.H.: Synthesis of a New Adrenal Imaging l Agent: 6-131-I-Iodomethyl-19-norcholest-5(10)-en-3B-ol (NP-59)., J. Nucl. Med., 16: 514, June, 1975.
41. Sarkar, S.D., Ice, R.D., Beierwaltes, W.H., Basmadjian, G.P., Hetzel, X.R., and Kennedy, W.P.: 6B-I-131-Iodomethyl-19-norcholest-5 (10)-en-3B-ol (NP-59)

Concentrates Iodocholesterol.,

in the Adrenal Gland Better than I-131 J. Nucl. Med., 17: 212-21, June, 1975.

21

wmnfv*T WNr Weemms f$rLCcanRC PAGF $9 a

42. Sarkar, S.D., Ice, R.D., Beierwaltes, W.H.,

Basamadjian, G.P., Xennedy, W.P. and Mosley, S.T.: Se-75-19-Selenocholesterol: A New Imaging Agent, J. Nucl.

Med., 15: 565, June, 1975.

I

43. Gill, S.P., Beierwaltes, W.H., Ice, R.D. and Mosley, S.T.: A New Radiolabeled Quinoline Analog in Mice and l i

Malignant Melanoma., J. Nucl. Med., 16: 530, June, )

1975.

44. Seabold, J.E., Beierwaltes, W.H., Zakem, J.F., Wieland, D.M. and Ice, R.D.: A New Radiopharmaceutical Approach for Adrenal Imaging Agent., J. Nucl. Med., 16: 566, June, 1975.
45. Ice, R.D.: " Pharmacy--Responding to Needs.", Faculty-Student Seminar, College of Pharmacy, The University of Michigan, Febrary 12, 1975.
46. Ice, R.D., Shaw, S.M., Born, G.S., George, R.E. and Hetzel, K.R.: The Role of the Nuclear Pharmacist in Nuclear Medicine., International Symposium on Radiopharmaceuticals, February 14, 1975, Atlanta, GA.
47. Ice, R.D.: Regulations for Nuclear Pharmacies.*, Dist.

8, 33rd Annual Meeting of the American Association of Colleges of Pharmacy and National Associatien of Boards of Pharmacy., San Francisco, California, October 13-15, 1974.

48. Ice, R.D.: Panel Discussion, Licensure of Radiopharmacies: Critique of the Arizona Regulations.,

NABP newsletter 4: 18, 1975.

49. Ice, R.D.: Nuclear Pharmacy Workshop, Pharmacy Services for Nuclear Medicine., J. Am. Pharm. Assn.,

NS15: 121, 1975.

50. Ice, R.D.: Panel Discussion, Symposium on Education in  !

l Nuclear Chemistry with Emphasis on Applications to I Nuclear Medicine., 170th National Meeting of the American IL.

Chemical Society, August 28, 1975, Chicago, l

\

l 22 l

04/30/1996 11:03 4048539325 GATECH NNRC PAGE 02

51. Ice, R.D.: Comments to FDA Radiopharmaceutical Advisory Committee., FDA Hearings, April 24, 1975, Washington, DC.
52. Ice, R.D.: Significant changea-Rules and Regulations in Nuclear Medicine. Central Chapter Meeting, Soc. of Nucl. Med. Detroit, March 5, 1976.
53. Gill, S.P., Beierwaltes, W.H., Ice, R.D. and Kramer, E.M.: Localization of Radiolabeled Phosphates in Breast Carcinoma, American Association for Cancer Research. J. Clin. Res. p. 107, March, 1976.
54. Hotte, C.E. and Ice, R.D.: A Kinetic Treatment of Radiopharmaceutical Decomposition. A.Ph.A. Annual Meeting, April 6, 1976, New Orleans, LA.
55. Ice, R.D.: Panel Discussion of Regulatory Control of Radiopharmaceuticals. 10th Annual Meeting, A.S.H.P.,

Washington, DC., December 9, 1975.

56. Rowles, S.G. and Ice, R.D.: Development of Rules Regulating Radiopharmaceuticals in Michigan, A.Ph.A.

Annual Meeting, April 6, 1976., New Orleans, LA.

57. Ice, R.D., Kircos, L.T., Coffey, J.L., Watson, E.,

Sakar, D.S. and Beierwaltes, W.H.: Radiation Dosimetry of 6-131-I-Iodomethyl-norcholesterol, Symposium on Radiopharmaceutical Dosimetry, April, 1976, Oak Ridge, Tennessee.

58. Sarkar, S.D., Cohen, E.L., Beierwaltes, W.H., Ice, R.D., Gill, S.P. and Gold, E.N.: 6-Beta-19-Nor-Iodocholesterol: A Superior Adrenal Imaging Agent in Humans, Endocrine Society, 58th Annual Meeting, Endocrinology 98: 242, June, 1976.
59. Beierwaltes, W.H., Wieland, D.M., Ice, R.D., Seabold, J.E., Sarkar, S.D., Gill, S.P. and Mosley, S.T.:

Uptake and Release of Radiolabeled Enzyme Inhibitors from Adrenal Cortex of the Rat and Dog, Endocrine Society, 58th Annual Meeting, Endocrinology 98: 58, June, 1976.

23

04/30/1995 11:03 4048539325 GATECH NNRC PAGE 03

60. Kirschner, A.S. and Ice, R.D.: The Theoretical Effect of Radiopharmaceutical Specific Activity of Absorbed Radiation Dose, Symposium on Radiopharmaceutical Dosimetry, April, 1976, Oak Ridge, Tennessee.
61. Ice, R.D.: Radiopharmaceutical Quality Control by Instant Thin Layer Chromatography, current Laboratory Practice, Gelman Instrument Company, May, 1976.  ;
62. Basmadjian, G.P., Kirschner, A.S., Mills, S.L., Barker, K. and Ice, R.D.: Formulation and Stability of 99m-Tc-Methylene Diphosphenate Kits. 1978 Annual Meeting, Am. ,

Pharm. Assn., Montreal, Canada, May, 16, 1978. j l

63. Basmadjian, G.P., Parker, G.R., Kirschner, A.S., Ice, R.D., Magarian, R.A. and Mills, S.L.: Facila Method for the Introduction of Te-123m Into Organic Molecules,  !

Synthesis of 3-Methyl-tellurocholesterol. SNM 25th l Annual Meeting, Anaheim, California, June, 1978. f

64. Sarkar, S.D., Cthen, E.L., Beierwaltes, W.H., Ice, R.D., Gill, S.P. and Gold, E.N.: 6B-19-Nor-Iodocholesterol (NP-59): A Superior Adrenal Imaging Agent in Humans, J. Nucl. Med., 17; 563, June
  • 1976.

~65. Wieland, D.M., Ice, R.D. and Beierwaltes, W.H.:

Synthesis of Radiolabeled Enzyme Inhibitors of the Adrenal Cortex, J. Nucl. Med., 17: 525, June, 1976.

66. Ice, R.D., Kircos, L.T., Coffey, J.L., Watson, E.,

Sarkar, S.D. and Beierwaltes, W.H.: Radiation Dosimetry of'I-131-6-Iodomethyl-norcholesterol, J.

Nucl. Med., 17: 540, June, 1976.

67. Ice, R.D., Keese, R.F., Shaw, S.M. and Wolf, W.: Final Report of the Special Committee on Radiopharmacy, Am.

J. Pharm. Ed. 39: 492, October, 1975. l

68. Prestidge, D.J. and Ice, R.D.: Nuclear Pharmacy Curriculum and Regulations, Sist Annual Meeting, Sixth District, NABP and AACP, Hot Springs, Arkansas, October 11, 1976.

Ice, R.D.: Special Session Radiopharmaceutics, 77th 69.

Annual Meeting, AACP, Minneapolis, MN., July 19, 1976.

24

04/30/1996 11:03 4040539325 GATECH NNRC PAGE 04 ,

t

70. Wieland, D.M., Kennedy, W.P., Ice, R.D. and Beierwaltes, W.H.: Radioiodinated Pyridines-Potential Adrenocortical Imaging Agents, J. Label Comp.  !

Radiopharm. 13: 299, 1977, September 23, 1976.

71. Yu, T., Wieland, D.M., Ice, R.D. and Beierwaltes, W.M.: Synthesis of Labelled 3-Iodocholesterols for ,

Adrenal Imaging, Abst. J. Label Comp. Radiopharm. 13:  ;

274, 1977.

72. ' Ice, R.D.: Technetium-99m: Physics, Chemistry, ,

Quality Control, Nuclear Radiology Workshop, The University of Michigan, Ann Arbor, MI, May 7, 1976.

73. Ice, R.D. and Hetzel, K.R.: Thin Layer Speeds Hospital Lab Assay, Industrial Research, C1, July, 1976. j i
74. Ice, R.D.: Nuclear Pharmacy Regulations at the Crossroads, 73rd Annual Meeting of NABP, May 24, 1977, St. Louis, MO.
75. Ice, R.D.: Dr. Ice, Assumes O.U. Dean Position, Oklahoma Pharmacist, Vol. 43, September, 1976.
76. Porter, M.E., Covington, T.R., Ice, R.D.: Fee Service, A Professional Practice Plan for Pharmacy Faculty, AACP Annual Meeting, Seattle, Washington, August, 1977.
77. Beierwaltes, W.H., Ice, R.D. and Kirschner, A.S.,

Effect of Specific Activity and Expression of Per Cent Uptake in Tissue, IAEA Symposium, Vienna Austria, December, 1974.

78. Ice, R.D.: Pharmacy Dean Named: College Moves to HSC, Update, 1, August, 1976.
79. Basmadjian, G.P., Ice, R.D. and Hetzel, K.R., Synthesis and Biodistribution of 75-Se-6-Benzylselenomethyl Norcholest-5-(10)-en-3B-ol (BseC). First Annual Meeting on General Radiopharmaceutical Science,.Jan.

22, 1978, Atlanta, GA.

80. Ice, R.D.: What is Clinical Nuclear Pharmacy and Where

. is it Going? Rocky Mountain Chapter of the Society of Nuclear Medicine, Albuquerque, New Mexico, April 6, 1978.

25 l

t4dr3L4T;#1f TgT63 dl#JWSSPJa3 L6TWCN 90Cic PAGE ~05

81. ' Ice, R.D.: The Pharacist and the Rural Health Team, Mid-Winter Faculty Convocation, Tulsa Medical College, Tulsa, OK. Feb. 18, 1978.
82. Ice, R.D., Basmadjian, G.P., Parker, G.R., Mills, S.L.,

Magarian, R.A. and Kirschner, A.S.: Tellurium-123m, A Substitute for Carbon in organic Radiopharmaceuticals, Rocky Mountain Chapter of the Society of Nuclear Medicine, Albuquerque, New Mexico, April 7, 1978.

83. Basmadjian, G.P., Mills, S.L., Parker, G.P., Kirschner, A.S., Ice, R.D. and Magarian, R.A., 16-Methyl Telluro-Te-123m-9-Hexodeconoic Acid: A Potential Mycecardial Agent. SNM 25th Annual Meeting, Anaheim, California.

June, 1978.

84. Basmadjian, G.P., Parker, G.R., Magarian, R.A.,

Kirschner, A.S. and Ice, R.D.: Potential Te-123m Radiopharmaceuticals: A simple method for the  !

Introduction of Te-123m Into Organic Compounds. J.

Labelled Compounds and Radiopharm. 16: 33-34, Jan.

1979.

85. Basmadjian, G.P., Ice, R.D., Magarian, R.A., Parker, G.R., Mills, S.L. and Kirschner, A.S.: Design and Development of Te-123m Labelled Radiopharmaceuticals.

Am. J. of Roentgenology 132: 487, March, 1979.

86. Gilliland, D.L., Basmadjian, G.P., Kirschner, A.S.,

Leonard, J.C., Ice, R.D. and Kurkjian, H.T.:

Development of a Lymphscintigraphy Agent. Second International Symposium on Radiopharmaceuticals Seattle, Washington, March 20, 1979.

87. Basmadjian, G.P., Magarian, R.A., Parker, G.R., Mills, S., Kirschner, A.S. and Ice, R.D.: 16-Methyltelluro-Te-1232-9-Hexadecanoic Acid: A Potential Myocardial Scanning Agent. J. Labelled Compounds and Radiopharm. 16: 160-161, Jan. 1979.
88. Ice, R.D. and Barker, K.: Nuclear Pharmacy Economics, Annual Meeting, American Pharmaceutical Association, Anaheim, CA, April 24, 1979.
89. Kirschner, K.S., Hinkle, G H., Basmadjian, G.P. and Ice, R.D.: Evaluation of a Kit Preparation of Radioactive 0-Iodohippuran. Annual Meeting, American '

Pharmaceutical Association, Anaheim, CA., April 24, 1979.

26

~~

~^1N/3@nj$)$n 11i$3~ '6@43339325'

~

GATECH tNRC PAGE 06

90. Basmadjian, G.P., Gilliland, D.L., Leonard, J.C.,

Kirschner, A.S. and Ice, R.D.: Para-aortic Lymph Node visulization in Dogs Using Tc-99m-Sn-PO4. J. Nucl.

Med. 20: 654, June, 1979.

91. Magarian, R.A., Parker, G.R., Basmadjian, G.,

Kirschner, A. and Ice, R.D.: Development of New Radiopharmaceuticals: Role of the Medicinal Chemist.

Sirth Annual MALTO Medicinal Chemistry-Pharmacognosy Meeting, The University of Mississippi, May 24-25, 1979.

92. Hinkle, G.H., Barker, K.K., Basmadjian, G.P. and Ice, R.D.: Clinical Nuclear Pharmacy: Paricipation in the Investigational New Drug Application, Annual Meeting, American Pharmaceutical Association, Washington, D.C.,

April 22, 1980.

93. Basmadjian, G.P., Ice, R.D., Parker, G.R., Magarian, R.A., Mills, S.L. and Kirschner, A.S.: Synthesis of Te-123m Nucleophiles: Potential Use in the Synthesis of New Te-123m Radiopharmaceuticals. Third International Symposium on Selenium and Tellurium Chemistry, Metz, France, July 12, 1979. .
94. Levine, G., Dirkson, J.W., Shaw, S., Ice, R. and Williams, R.: A Brief History of the Apha, Academy of Pharmacy Practice, Section of Nuclear Pharmacy--1973 Was Indeed a Very Good Year. Annual Meeting of the American Pharmaceutical Association, American Institute History of Pharmacy, April 24, 1979, Anaheim, California.  :

1

95. Ice, Rodney, D.: "What Nuclear Pharmacy Needs Now" Invited Lecture, Joint Session, Academies of Pharmacy Practice and Pharmaceutical Science, American Pharanceutical Association Annual Meeting, Washington, D.C. April 22, 1980.
96. Ice, R.D.: Perspectives on Nuclear Pharmacy Regulations (two presentations). National Conference on Regulation and Inspection of Nuclear Pharmacies, Albuquerque, New Mexico, November 18-19, 1980.

27 l

}

vurwrs% Kinn nesamh e5ntcRrwt-c rMGC'Mr

97. Ice, R.D.: Nuclear Energy-Cure or Crisis, Keynote Lecture, Bienfang Seminar, University of Oklahoma, Tulsa, Oklahoma. November 8, 1980. (Variations of this presentation were given to the Christian Medical Society and numerous Rotary, Kiwanis, Engineer Clubs and Pharmacy Associations).
98. Ice, R.D.: "Ph.D. Programs in Nuclear Pharmacy,"

Invited Lecture, Nuclear Pharmacy Section, Academy of Pharmacy Practice, American Pharmaceutical Association Annual Meeting, St. Louis, MO, March 31, 1981.

99. Barker, K.K., Basmadjian, G.P., Hinkle, G.H. and Ice, R.D.: " Interdisciplinary Approach to Radiopharmaceutical-Pharmaceutical Interaction Screening," Academy of Pharamcy Practice, American Pharmaceutical Association Annual Meeting, St. Louis, Missouri, March 30, 1981.

100. Hinkle, G.H., Basmadjian, G.P., Peek, C., Barker, K.K.

and Ice, R.D.: " Abnormal Distribution of Tc-99m Gluceptate Sodium," Academy of Pharmacy Practice, American Pharmaceutical Association Annual Meeting, St.

Louis, Missouri, March 30, 1981. ,

101. Fung, T.J., Basmadjian, G.P., and Ice, R.D.: Nuclear Pharmacy Management Information Retrieval System, First European Symposium on Radiopharacy and Radiopharmaceuticals, Copenhagen, Denmark, March 30, 1983.

102. Basmadjian, G.P., Sadek, S., and Ice, R.D.: Selenium Se-75 Radiopharmaceuticals, 4th Int. Conf. on the organic Chemistry of Selenium and Tellurium, Birmingham, England, July, 1983.

103. Basmadjian, G., Johnston, J., Barker, K., and Ice, R.:

" Trends in Radiopharmaceutical Dipensing in a Regional Nuclear Pharmacy". Academy of Pharmacy Practice, American Pharmaceutical Association Annual Meeting, Las Vegas, Nevada. April 1982 and Third World Congress of Nuclsar Medicine and Biology, Paris, France, Sept. 2, 1982.

104. Basmadjian, G.P., Fung, T-C. J., Barker, K.K. and Ice, R.D.: Nuclear Pharmacy Management Information Retrieval System, 130th Annual Meeting of the American Pharmaceutical Assn., New Orleans, LA, April 9-14, 1983.

28 l

_ _ _ . _ _ _ . ~ ~ ~

08~ ~

. r i

105. Chan, S.M., Basmadjian, G.P., Marten, D.F., Sadek, S.,  ;

Margarian, R.A., Grunder, J.R. and Ice, R.D.: j Synthesis and Biodistribution of Radioiodinated 5-Iodo- '

Nicotine: Society of Nuclear Medicine 30th Annual Meeting, St. Louis, MO. June 7-10, 1983: J. Nucl. ,

Med, and Biol. 24/P116/1983.  !

106. Gilliland, D.L., Basmadjian, G.P., Marchand, A.P., l Hinkle, G.H. and Ice, R.D.: Iodine Labelled  !

Radiopharmaceuticals from Arylthallium bis (trifluoracetate) Intermediates. Banff Conf., 1982.

l 107. James, M.R., Basmadjian, G.P., Leonard, J.C. and Ice, R.D.: Desferoxamine Mesylate: Its use in Reducing ,

Radiation Burden in Pediatric Patients Injected with  :

Gallium-67 Citrate. 3rd.World Congress of Nucl. Med.

and Biol. Paris, France, Aug. 1982.

108. Basmadjian, G.P., Mills, S.L., and Ice, R.D.: 6 Synthesis, Biological Distribution and Radiation Dosimetry of Te-123m Analogues of Hexedecanoic Acid.

3rd World Congress of Nucl. Med, and Biol. Paris, France, August 1982.

109. Basmadjian, G.P., Sadek, S., and Ice, R.D.: S nthesis of 75-Selenium-labeled catecholamine Derivatives:

Adrenal Medulla Tumor Specific Radiopharmaceuticals, 4th Int. Symp. on Radiopharmaceutical Chemistry, Julich FRG, August 26, 1982.

110. Basmadjian, G.P., Gilliland, D.L., Marchand, A.P.,

Magarian, R.A., and Ice, R.D.: Synthesis of Radiciodinated Cis-and Trans-1,2-Diphenyl-3, 3-Dichloro-cyclopropanes: Potential Radiopharmaceuticals for Estrogen Dependent Tumors, Int. Symp. in Radiopharmaceutical Chemistry, Julich FRG, August 26, 1982.

111. Ice, R.D.: Nuclear Pharmacy Practice in Russia and China, 131st Annual Meeting of the American Pharmaceutical Assn., Montreal, Canada, May 5-10, 1984.

112. Ice, R.D.: I-123 vs I-131 and Tc-99m for Thyroid Imaging. loth Annual Meeting of the Georgia Society of Nuclear Medicine Technologist, Stone Mt., GA, April 28, 1984.

29

_-- _ _ - m i

113. Ice, R.D: Book review, Medication and the Elderly by W. Simonson, J. Gerontology, 39, 510, April 1984.

114. Chan, S.M., Basmadjian, G.P., Marten, D.F., Sadek, S.,

Magarian, R.A., Grunder, J.R. , and Ice , R.D. :

synthesis and Biodistribution of Radiciodinated Nicotine Analogs. J. Nucl. Med. 25/P121/84. Presented at the 1984 Annual Meeting, Society of Nuclear Medicine, Los Angeles, CA, June 13, 1984.

115. Ice, R.D.: Future Development in Radiopharmaceuticals, Missouri valley Chapter Society of Nuclear Medicine, Oct. 14, 1984.

116. Ice, R.D., Moderator: International Symposium on Drug Quality Assurance in the Hospital, Toronto General Hospital and University of Toronto, June 11, 1984.

117. Ice, R.D , Boron-10 Precursor Products for Boron Neutron Capture Therapy, Workshop, Radiation Research Program, National Cancer Institute, May 3, 1988.

118. Pham, T., Edens, B., Potts, T., Shaw, M. and Ice, R.D.: The role of Isotopic B-10 as a Tracer in the Preparation of Decaborane, Boron USA (BUSA II),'Raleigh- l Durham, NC, 1990. )

1 119. Ice, R.D., Neutron Capture Therapy, A.Ph.A Annual  !

Meeting, New Orleans, 1991. l 120. Morre', D.J., Ice, R.D., and Boone, J.: Color-Change-Based Detection of Bacterial Toxins, US Army Chemical Research, Development and Engineering Center, Scientific Conference on Chemical Defense Research, Nov. 1991.

C. CHAPTERS IN BOOKS

1. " Radioactive Dosage Forms", Sprowl's American Pharamey, 7th Ed., Edited by R.W. Dittert, Lippincott, Philadelphia, 1974. pp 423-450.
2. " Design of Radiopharmaceuticals," Drue Desian, Vol. VI,

. Edited by E.J. Ariens, Academic Press, N.Y., 1975.

3. " Sterilization and Sterility Testing" ouality Control in Nuclear Medicine, Edited by B.A. Rhodes, C.V. Mosby and Co., St. Louis, MO, 1977.

30

_ _ - __ _ _ _-_ _ __+ __

evrwnreeermnma - ewsom wa, rm a l

\

l 1

4. " Nuclear Pharmacy," Handbook of Institutional Pharmacy Practice Edited by M.C. Snith and T.R. Brown, Williams and Wilkens, Baltimore, MD, 1979, pp. 449-458. j
5. " Practical Generator Kinetics," Basics of Radiopharmacy by B.A. Rhodes and B.Y. Howard, C.V.

Mosby Co., St. Louis, MO 1978, pp. 163-172.

6. Ice, R.D. and Wright, M. Sister: MABP Persnactives on Ruglear Pharmacy Reaulations, Proceedinas of a National
conf. on Ranulation and Inspections of Nuclear Pharmacies, p. 69-74, Ed. by Friedman, B.E. and Hladik, W.B. III, College of Pharmacy, Univ. of New Mexico, Albuquerque, N. Max., 1982.
7. Ice, R.D.: Conference Highlights, Proceedings of a National Conf. on Regulation and Inspections of Nuclear Pharmacies; p. 112-117, Ed. by Friedman, B.E. and Hladik, W.B. III, College of Pharmacy, Univ. of New Mexico, Albuquerque, N. Mex. 1982.

~

8. " Clinical Use of Radiopharmaceuticals,"

Radionharmaceuticals and other Applications of Radioactivity and Radiation in Medicine, Edited by S.M.

Shaw and R.E. George, Marcel Dekker, Inc. N.Y.*, 1980.

9. Hladik, W.B., Ponton, J.A. and Ice, R.D.: Chapter VI.5

" Nuclear Pharmacy" in Handbook of Institutional Pharmacy Practice, Edited by Brown, R. and Smith, M.C.,

Williams and Wilkins, Baltimore, MD, 1985.

10. Ice, R.D. and Shaw, S.M., "Radiopharmaceuticals", in Ausman and Snyders, Medical Library, Lawyers Edition, 1992.

I i D. BOOKS I

1. Radiopharmaceuticals II: Edited by Sodd, V.J., Allen, D.R., Hoogland, D.R. and Ice, R.D., Society of Nuclear Medicine, New York, NY, 1979.

E. PATENT

1. Bacterial Toxin Biosensor, Patent Applied Nov. 1991 F. VISITING PROFESSCRSHIPS AND NON-ABSTRACTED PRESENTATIONS AT PROFESSIONAL MEETINGS
1. Ice, R.D., Breckingridge, C.E. and Christian, J.E.:

" Synthesis of 131-I-2,3,5-Triiodobenzoic Acid," TIBA Workshop, Int. Min. and Chem. Corp., Skokie, Illinois, September, 1965.

4 31

- oo ;

I

2. Ice, R.D., Christian, J.E. and Plumlee, M.P.: "TIBA I Distribution, Metabolism, and Whole Body Retention in Goats," TIBA Workshop, Int. Min. and Chem. Corp.,

Skokie, Illinois, 1966. l

3. Ice, R.D.: " University Radiation Safety Practices, 2nd l National Conference of University Radiation Safety officers, Renssalear Polytechnic Institute, Troy, NY, August, 1969.

1

4. Ice, R.D.: "Radiopharmaceuticals," Delaware Valley '

Society of Hospital Pharmacists, Philadelphia, PA.,

May, 1970.

5. Ice, R.D.: Visiting Professor, Radiological Health, l Rutgers University, New Brunswick, New Jersey, l November, 1970. '
6. Ice, R.D.: Visiting Professor, Nuclear Pharmacy, Purdue University, Lafayette, IN, April, 1973.
7. Ice, R.D.: Visiting Professor, Nuclear Pharmacy, Ferris State College, Big Rapids, MI, March, 1974.
8. Ice, R.D.: Visiting Professor, Nuclear Pharmacy, University of Miami, Miami, Florida, April, 1974.
9. Ice, R.D.; Visiting Professor, Nuclear Pharmacy, University of Southern California, May, 1975.
10. Ice, R.D.: Visiting Professor, Nuclear Paarmacy, University of California at San Francisco, October, 1975.
11. Ice, R.D.: "A Christian View of Energy and Ecology", l University of Oklahoma, Christian Medical Society, l April 6, 1980.
12. Ice, R.D.: Visiting Professor, College of Pharmacy, N.E. Louisiana State University, March 19, 1981.

i L

i 32 i

- - was as ,

I III. GRADUATE STUDENT GUIDANCE A. Master af Sciance Tonic

1. Bogucki, E.I. 1967 Dental X-Ray Dosimetry
2. Cassara, R.D. 1968 Philadelphia Radiation Safety
3. Clemons, P.E. 1969 TLD of Panographic X-Rays
4. Kaufer, G. 1969 Radionuclide Chelation Therapy
5. Pettingill, H.J. 1971 Tc Labeled Fibrinogen
6. Troetel, W. 1969 Synthesis of C-14 Meperidine
7. Bartlett, J.M. 1970 Tc Labeled Fibrinogen
8. Bicehouse, H. 1970 Binding of Organic Tritium
9. Bercz, C.V. 1970 Synthesis of Meperdine Precursor
10. Briden, D. 1970 Neutron DosimetryIII.
11. Jenckes, T. 1970 TLD in a University R.C.O.
12. Monte, J. 1970 Radioassay of Environ-mental PBI
13. Hetzel, K.R. 1971 Tc0 Colloid
14. Kirschner, A. 1971 11-C-Dopamine .
15. McAuley, R. 1973 Pyrogen Detection by "Linulus"
16. Ihlenfield, W. 1974 Species Specificity of Radiopharmaceuticals
17. Shen, Victoria 1975 Xenon-133 Waste Disposal
18. Wetherill, Roger 1975 Dosimetry and Decomposi-tion of Para RIBA.
19. Lamson, Myles 1977 Technetium Chemistry
20. Behm, Harriet 1977 Nuclear Pharmacy Practice B. Doctor gi Pharmacy
1. Kelly, W. 1972 Evaluation of TcS Colloid for Human Use i
2. Hotte, C. 1972 Radiodecomposition of Iodocholesterol
3. Nelson, S. 1972 I-131 Labeled Fibrinogen
4. DeSpigno, V. 1972 Technetium Medicinal Chemistry

, 5. Clayton, B. 1973 Clinical Evaluation of '

Technetium Macro-aggregated Albumin

6. Scheife, R. 1973 Labeled Cleic Acid for Myocardial Scanning
7. Porter, W. 1974 Establishment of a Nuclear Pharmacy 33

06/30/1996 11:03 4048539325 GATECH NNPC PAGE 13 B. Doctor g{ Pharmacy (con't)

8. Vellucci, A. 1974 Tc-99m Dithizone for
9. Robertson, J. Pancreas Scanning 1975 Dosimetry and Decomposi-
10. Merryman, R. 1975 tion of Selenocholesterol
11. Vivian, A. Thioglucose Labeling 1976 Radiochemical Purity Evaluation C. Doctor g{ Philonochv
1. Dugan, (Leoper) M. 1971 Gonadal Dosimetry of Tritiated Thymidine
2. Monte, (Piccone) J. 1973 Tumor Detection by
3. Kerschner, A. Ultrasound 1975 Pharmacokinetics of 4.' Hotte, C. Tissue Specific Drugs 1976 Radiopharmaceutical
5. Mills, S. stability 1980 Tellurium Labeled Fatty Acids D. Post Doctoral
1. Wieland, D. 1973 q
2. Basmadjian, G.

1974

3. El Masry, A.H.

1975

4. Yu, Terry 1976 l
5. Mukadopating, Sunil 1976 j

I

6. Parker, G. 1978
7. Sadek, S. 1981 IV. RESEARCH A. Areas of Interest
1. New Products Design and Development
2. Radiopharmaceuticals B. Current Projects I

1.

Boron Neutron Capture Therapy i

2.

Theoretical Stability Considerations of Radiopharmaceutical

3. Membrane Receptor Biosensors 4.

Isotopic lithium chemistry and physics 34

04/30/1996 09:33 4048539325 GATECH NNRC PAGE 02 t ..

l l .

l CURRICULUM VITAE January 1994 l

I. PERSONAL RECORD l

1. NAME: Rodney Dean Ice
2. SEX: Male l
3. BORN: Spril 24, 1937, Fort Lewis, Washington
4. MARRIED: March 21, 1958, Olympia, Washington
5. WIFE'S MAIDEN NAME: Joan Elizabeth McCullough
6. CHILDREN: Randal Dean Ice, April 6, 1959 Rex Daryl Ice, February 19, 1961 Ronald Dale Ice, April 30, 1963
7. EDUCATION:
a. William Winlock Miller High School, Olympia, WA, 1955
b. University of Washington, Seattle, WA, B.S. l Pharmacy, 1959 l

1

c. Purdue University, West Lafayette, IN, M.S., 1965
d. Purdue University, West Lafayette, IN, Ph.D., 1967
8. GRADUATE TRAINING 1
a. 1965, M.S.

Major: Radiological Health Minor: Public Health (Sanitary Engineering)

Minor: Analytical Chemistry

. b. 1967, Ph.D.

I Major: Radiological Health l Minor: Pharmaceutics

!; 9. ACADEMIC APPOINTMENTS and/or EXPERIENCE

a. 1992-present, Principal Research Scientist, Manager
of Office of Radiation Safety, Georgia Institute of j Technology, and Adjunct Professor, Health Physics Program, Georgia Institute of Technology.

1 CE--3

06/30/1996 09:33 4046539325 GATECH NNRC PAGE B3 i

i b 1985-1992, Vice President and Director of Research, Eagle-Picher Industries (NYSE), Inc. (Self-Supporting Research Facility, $10M budget, 55 person staff).

c. 1983-1985, Vice President of Corporate Development, I Benedict Nuclear Pharmaceuticals, Golden, CO.

(Responsible for Research Department, Professional Affairs Department and University Liaison Office).  !

d. 1976-1983, Dean and Professor of Pharmacy, Collene of Pharmacy, University of Oklahoma, Health Sciences Center, Oklahoma City, OK. (Responsibis ,

for $2M budget, 25 full-time faculty, 40 adjunct i faculty, and 400 students) l

e. 1976-1983, Assoc. Prof., Dept of Radiology, School of Medicine, University of Oklahoma, Oklahoma City, OK.
f. May-September 1982, Visiting Scholar , University of Michigan, Ann Arbor, MI.
g. 1976, Professor of Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI. ' Taught Health Physics and Radioisotopes in Medicine).
h. 1971-1976, Assistant and Associate Professor of l Internal Medicine, University of Michigan, Ann  !

Arbor, MI.

i. 1971-1976, Associate Professor of Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI.
j. 1971-1976, Director, Radiopharmaceutical Services, University Hospital, University of Michigan, Ann Arbor, MI.
k. 1970-1971, Associate Professor of Radiochemistry, Temple University, Philadelphia, PA. (Taught graduate courses in Radioisotope Methodology, Health Physics and Nuclear Pharmacy).
1. 1967-1970, Ausistant Professor Radiochemistry, Temple University, Philadelphia, PA.
m. 1967-1970, Radiation Safety Officer, Temple University, Ph.iladelphia, PA.
n. Health Physics St.,:iety Summer School
1) Philadelphia, PA, July 2-6, 1980
2) New Orleans, LA., May 28-June 1, 1984

m m entturrviuc ems .

l 1

o. May 19-23, 1969, Course on "Non-Ionizing Radiation," l U.S.P.H.S., Bethesda, MD.  ;
p. 1964-1967, Radiological Health Fellow, Scaool of Pharmacy and Pharmacal Sciences, Purdue University,  !

West Lafayette, IN.

l

q. 1959-1965, Owned and Operated Rod's Tanglewilde Drugs, l 6515 Martin Way, Olympia, WA.

l

r. 1955-1959, Pharnacist and Intern, Freed's Pharmacies, I i

Seattle, WA: Gillette and Guffey Drugs, Olympia, WA.

10. CONSULTING POSITIONS
a. National Assn. Boards of Pharmacy 1974-1986 l
b. University of Tennessee, Memphis 1980 l l
c. Department of Health, City of Philadelphia, 1968-1976 1
d. Veterans Administration Hospital, Ann Arbor, MI 1972-1976
e. Veterans Administration Hospital, Allen Park, Mk 1976
f. Searle Laboratories, Chicago, Illinois, 1975
g. Smith, Kline and French, Philadelphia, PA 1970
h. Philadelphia Technical Institute, Philadelphia, PA 1968-1969
11. CERTIFICATION AND LICENSURE
a. Certified Health Physicist, erican Board of Health Physics, 1972 (Recertified, 30, 1985, 1990)
b. Washington State Board of Pharmacy, 1959-Present
c. California State Board of Pharmacy, 1959-Present
d. Michigan State Board of Pharmacy, 1972-1988 ,
e. Oklahoma State Board of Pharmacy, 1977-Present 3

G4/30/1996 09:33 4640539325 GATECH NNRC PAGE 05

12. MILITARY SERVICE
a. 1981-Present, COL., USAR, Medical Service Corps
b. July, 1958, Commissioned Officer, Medical Service Corps
c. 1957-1958, Graduate, Washington Military Academy (Infantry, Officers Candiate School)  ;
d. 1953-1963, Washington State National Guard
13. HONORS '

i

a. Rho Chi 1
b. Sigma Xi  !
c. Dean's List
d. International Scholars Directory i
e. Who's Who in the Midwest, 15th and 16th Ed.

l

f. American Men and Women of Science, 13th, 14th,.15th and 16th Ed.
g. Dictionary of International Biography, Vol. 14 and 18
h. Who's Who in Health Care, 1st & 2nd Ed.
1. Community Leaders and Noteworthy Americans, Am.

Biograph. Inst.

j. Who's Who in the World, Vol. 6
k. University of Oklahoma Alumni, Outstanding Pharmacist Award, 1979 1
1. Personalities of the South, loth & lith Ed. I
m. American Biography of the Medical Sciences, 1978 ,
n. Who's Whoein,2 23rd Edv the,& South and Southwest, 17th, 20th,jf

, 'i .-t a a gSf (d.

o. Directory _of..H.uclear Medicine, Butterworth, 1981
p. Who's Who in America, 42nd, 43rd & 44th Ed.

4

^

e4/20/1996 0 09:33 404B539325 GATECH NNRC PAGE 06

q. American Pharmaceutical Association, Academy of 4

Pharmacy Practice, Service Award, 1983

r. Biographical Directory of Occupational and safety Specialists, let Ed.
s. Purdue University "Old Master" Award, 1986
t. Who's Who in Science and Engineering, 1st Ed., 1992-1993
u. Who's Who in American Education, 3rd Ed.
v. Ponca City, Oklahoma Service Recognition Award, 1991
w. Who's Who, Environmental Registry, 1992
x. Oxford's, Whose Who, 1992

.%' , m. , < w . ~ .a , . > y,; . ,,,,,

14. MsMB5RSNYE$ "fN "NOFNSENCIOEIETIES a 1991-present Internations Isotope Society
b. 1955-present American Pharmaceutical Association
c. 1967-present American Association for the Advancement of Science
d. 1965-present Health Physics Society
e. 1970-present American Scientific Affiliation
f. 1971-present Society of Nuclear Medicine
g. 1968-present "-

American Association of Colleges of

( Pharmacy

h. 1976-1983

' Oklahoma State Pharmaceutical Association

i. 1973-1J C American Institute History of Pharmacy
j. 1955-1976 Washington State Pharmaceutical Assn.
k. 1955-1974 American Public Health Assn.
1. 1968-1974 Conference of Radiological Health
m. 1967-1971 Delaware Valley Radiation Protection Society
n. 1959-1965 Southwest Washington Pharmaceutical Assn.
o. 1962-1963 Puget Sound Pharmaceutical Assn.
15. POSITION HELD IN ABOVE SOCIETIES i
a. American Association of Colleges of Pharmacy  !
1) Delegate, 1975, 1976, 1977, 1978 l
2) Academic Affairs Committee, 1976, 1977, 1978
b. American Pharmaceutical Association
1) Chairman, Nuclear Pharmacy Section, Academy of Pharmacy Practice, 1977-1978
2) Nuclear Pharmacy Committee of Legislative

. nffairs, 1976

3) Nominating Committee, 1979-1980
4) Regulatory Affairs Committee 1980-1981, 1983-1984 5

04/30/1995 09:33 4348539325 GATECH NNRC PAGE 07 i

a

c. Delaware Valley Radiation Protection Society, President Elect, 1969; President, 1970
d. Delegate to American Pharmaceutical Association Meeting, t Washington State, 1964 Academy of Pharmacy Practice, 1978 Oklahoma State, 1981
e. Southwest Washington Pharmaceutical Association Secretary, 1960-1961 President Elect, 1962 President, 1963 -
16. COMMITTEE AND ADMINISTRATIVE SERVICE ton .ms s us e.
  • r . ,. . ,, .- . .~. ~ , N ,. .,. ,c . m

. - -*- ' <t

1. 1980-1990, Revision Committee, United States Pharmacopeia
2. 1977-1984, Board of Pharmaceutical Specialties, Specialty Council of Nuclear Pharmacy.
3. 1968-1985, Representative of the American Pharmaceutical Association to the United States Standards Institute Committee, N-44, " Equipment and Materials for Medical Radiation Applications."
4. 1976-1978, Trustee, Radiopharmaceutical Science Council, Society of Nuclear Medicine
5. 1976-1979, Editorial Advisory Board, U.S.

Pharmacist New York, NY

6. 1974-1977, American Association of Colleges of Pharmacy, Subcommittee of Nuclear Pharmacy, (Chairman, 1976)
b. State
1. 1980-81, Membership Committee, oklahoma Pharmaceutical Assn., State of Oklahoma
2. 1975-1976, Chairman, Radiopharmaceutical Advisory Advisory Committee, Michigan Board of Pharmacy, Department of Licensing and Regulation, State of Michigan
3. 1973-1976, Chairman, Governor's Radiation Advisory Committee, State of Michigan.

6 d

ea/3e,/39ss 09:33 4e42539325 GATECH NNRC PAGE 08 l

I I

c. University of Oklahoma i
1. 1981-1982, HSC LRP, and Affirmative Action  !

2.

1979-1982,sOK Teaching Hospitals P & T Committee '

3. 1976-1983(/ Radiation Safety Committee
4. 1976-1983, Dean's Council
5. 1976-1983, V.A. Administration Dean's Committee  !
d. University of Michigan
1. 1975-1976, Chairman, Graduate Affairs committee i
2. 1973-1976, Educational Resources Committee 3.

1972-1976, Executive Committee, College of Pharmacy

4. 1972-1973, Faculty Senate
5. 1974-1975, Alumni Lecture Committee
6. 1972-1976, Graduate Research Support Committee
e. Temple University
1. 1970-1971, Head, Bionucleonics Division (Radiological Health, Nuclear Pharmacy, Radiation Safety Office, 4 Faculty, 7 Staff)
2. April 18-19, 1969, Chairman Workshop on Thermoluminescent dosimetry, Jefferson Medical Center, Jefferson University, Philadelphia, PA
3. 1967-1971, Radiation Protection Committee
a. University Policy Committee (Chairman 70-71) b.

4.

Health Sciences (Chairman 1967-1971) 1969-1971, Human Use Committe t

5. 1968-1971, School of Pharmacy
a. 1968-1970, Equipment Committee (Chairman 69-70)
b. 1968-1969, Admissions Committee
c. 1968-1969, Graduate Committee i

M 1968-1971, Student Activites Committee  !

6. .%03-1971, Faculty Advisor, Phi Delta Chi Pharmacy Faternity '
7. 1967-1970, Administered Radiation Safety Office (6 staff)
f. Reviewer (Current)
1. The Journal of Nuclear Medicine
2. Am. J. Hospital Pharmacy
3. Journal of Medicinal Chemistry  ;
4. Encyclopedia of Chemical Technology i
17. COMMUNITY SERVICE
a. 1991-present, Board of Trustees, Bacone College, Muskogee, OK.
b. 1991 Technical Advisory Committee, City of Miami,0K
c. 1989 - present, Member, Management Advisory Board, Center for Space Power, Texas A&M University
d. 1975, Executive Chairman for Billy Graham Assn.,

Washtenaw Co., "The Hiding Place" film.

e. 1974, Executive Chairman for Billy Graham Assn.,

Washtenaw Co., " Time to Run" film.

f. 1971-1980, Board of Trustees, Philadelphia College of n Bible, Philadelphia, PA.
g. Church Membership
1. 1987-present, First Baptist Church, Miami, OK (Adult Sunday School Teacher, Choir)
2. 1977-1981, Metropolitan Baptist Church, Oklahoma City, OK
3. 1971-1977, Packard Road Baptist Church (Adult Sunday School Teacher, Deacon, Choir)
4. 1968-1971, Wharton Baptist Church, Philadelphia, PA (Sr. Migh Sunday School Teacher, Choir, Deacon)
5. 1964-1968, First Baptist Church, Lafayette, IN (Substitute Sunday School Teacher)
6. 1953-1964, First Baptist Church, Olympia,.WA (Sunday School Teacher, Sunday School Superintendent, Choir, Junior High Youth Leader)
h. 1970-present, Gideons International (President, Ann Arbor Camp-1973)
1. 1961-1964, Christian Business Men's Club, Olympia, WA II. BIBLIOGRAPHY A. Publications
1. Ice, R.D., Master's Thesis: A Study of the Retention, Excretion, and Distribution of 2,3,5-Triiodobezoic Acid and Its Metabolites in the Rat, Graduate School, Purdue University, Lafayette, IN., August, 1965.
2. Ice, R.D., Breckinridge, C.E., Jr., and Christian J.E.: Retention, Excretion and Distribution of 2,3,5-Triiodobezoic Acid and Its metabolites in the Rat, J.

Pharm. Sci., 55: 497-500, 1966.

3. Ice, R.D., Doctoral Dissertation: The Metabolic Fate of Orally Administered 2,3,5-Trilodobenzoic Acid and Its Metabolites in Lactating Animals, Graduate School, Purdue University, Lafayette, IN., June, 1967.

8

W4/30/1996 09:33' 4048539325 GATECH NNRC PAGE 50

4. Ice, R.D., Christian, J.E., and Plumlee, M.P.:

Metabolic Fate of Orally Administered 2,3,5-Triiodobenzoic Acid in Lactating Animals, J. Pharm.

Sci., 57: 399-404, 1968.

5. Dugan, M.A., and Ice, R.D.: Beta Emitter Indentification by Quench Analysis, Organic j scintillators and Liquid Scintillation Counting, i Horrocks, D.L. and Peng, C.T., Ed., 1055-1062, Academic Press, 1971.
6. Ice, R.D.: Establishment of a University Radiation Safety Office, Health Physics, 20: 444-446, 1971.
7. Ice, R.D. and Dugan, M.A.: Beta Radiopharmaceutical Identification by Quench Analysis, J. Nucl. Med., 12: ,

552-554, 1971. l

8. Ice, R.D., Updagrave, W.J. and Bogucki, E.I.:

Influence of Dental Radiographic Cones on Radiation Exposure, J.A.D.A., 83: 1297-1302, 1971.

9. Bercz, C.V. and Ice, R.D.: Synthesis of 1-Carbethoxy  !

cyano-4-phenylpiperidine, J. Pharm. Sci., 61: 1316-1317, 1972.  !

10. Lieberman, J.E., Ice, R.D., Green, M. and McGratten, R: Summary of Environmental Monitoring at i Philadelphia, 1958-1971, Radiological Health Data and l

Reports, 14: 333-350, 1973.  ;

11. Kirschner, A.S., Ice, R.D., and Beierwaltes, W.H.

Radiation Dosimetry of I-19-Iodocholesterol, J. Nucl.

Med. 14: 713-717, 1973. ,

)

12. Kelly, W.N. and Ice, R.D.: Pharmaceutical Quality of Technetium-99m Sulfur Colloid, Am. J. Hosp. Pharm.,

30: 817-820, 1973.

13. Ice, R.D. and Hetzel, K.R.: Radiation Protection in a Nuclear Pharmacy, Proceedings of the Third International Congress of the International Radiation Protection Association, Sept. 9-14, 1973, Washington, D.C., 1197-1202. Conf. 730907, USAEC, Oak Ridge, TN.
14. Hotte, C. and Ice, R.D.: Thermal and Radiolytic Decomposition of 131-I-19-Iodocholesterol, J. Nucl.

Med., 15: 38-41, Jan.,1974.

9 l

Retrieved from "https://kanterella.com/w/index.php?title=ML20115F481&oldid=2809136"